Eslicarbazepine acetate add‐on for drug‐resistant partial epilepsy
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To evaluate the efficacy and tolerability of ESL when used as an add‐on treatment for people with drug‐resistant partial epilepsy.